Both in Biotechnology
Relay Therapeutics vs Beam Therapeutics
Over the past year RLAY returned +162.8% and BEAM returned +22.2%; their daily moves had a correlation of 0.38.
RLAY +162.8% BEAM +22.2%Growth of $1, one year, split-adjusted
| Metric | RLAY | BEAM |
|---|---|---|
| Price | $18.03 | $27.79 |
| Market cap | $3.95B | $2.87B |
| Today | +3.38% | +5.54% |
| 1 month | −3.8% | +10.1% |
| 6 months | +39.6% | −14.1% |
| Year to date | +113.1% | +0.3% |
| 1 year | +159.8% | +14.6% |
| Revenue growth (YoY) | −48.3% | −94.2% |
| Gross margin | 100.0% | 100.0% |
| Net margin | −23916.3% | −25036.3% |
| P/E (TTM) | — | — |
| Price / sales | 381.8× | 18.4× |
| Net cash | $910.9M | $1.05B |
| Dividend yield | — | — |
| Volatility (60d) | 49.2% | 64.2% |
| Short % of float | 27.9% | 32.0% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).